Varenicline for Smoking Reduction in Veterans Not Ready To Quit

Starting soon · Phase 4

Conditions studied: Veterans, Tobacco Use Disorder, Cigarette Smoking, Tobacco Dependence

In brief

In order to reduce the prevalence of cigarette smoking among Veterans, it is vital that healthcare providers offer effective tobacco treatment to all Veterans who smoke, including those not ready to make a quit attempt. Smoking treatments currently available to Veterans who are not ready to quit are only weakly effective. This project will generate new knowledge about the effectiveness of a promising varenicline-based intervention designed to increase quit attempts and long-term abstinence in Veterans who are initially not ready to quit. This project has great potential to engage Veterans not ready to quit smoking in treatment that increases quit attempts and quitting success, thereby reducing morbidity and mortality caused by smoking in Veterans.

Key facts

Study ID
NCT06966362
Run by
VA Office of Research and Development
People needed
400
Starts
2026-08-17
Expected to finish
2030-06-28
Last updated by the study team
2026-07-31

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.